SRPT - Sarepta Sotuvning sof marjinal rentabelligi

Sarepta - SRPT emitenti grafik logotipi

DNA modellashtirishda AI ning qo'llanilishi dori vositalarini ishlab chiqishni tezlashtirmoqda, bu esa Sarepta Therapeutics, Inc. (SRPT) uchun tebranishlarni keltirib chiqarmoqda. Haqiqiy savdo marjalari spekulyatsiyalarni filtrlashga yordam beradi, bunda joriy ko'rsatkich -5.90 darajasida turibdi. RNA terapiyasi bo'yicha yetakchilik va gen tahrirlashga kiritilgan keng ko'lamli investitsiyalar barqarorlik poydevorini ta'minlaydi. Doug Ingram ning professional boshqaruvi tartibga soluvchi to'siqlarni muvaffaqiyatli yengib o'tmoqda va innovatsion mahsulotlarni samarali tijoratlashtirmoqda.

Sarepta Corp (SRPT) Sof foyda marjasi: 04.07.2022 - 20.11.2026 davri uchun

SRPT (Sarepta Therapeutics, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi statistikasi:
Kompaniyaning fundamental baholanishi:Sarepta Therapeutics - SRPT
Sarepta Corp tayyor mahsulotlari

Tebranishlar davrida kapitalni himoya qilish uchun sof daromadlilikni kuzatish muhimdir, chunki u barcha xarajatlar chegirib tashlanganidan keyin har bir dollar daromadning qancha qismi foyda ekanligini belgilaydi. Kompaniya savdo marjalarini tahlil qilish orqali investor biznes samaradorligini baholaydi, bu esa Sarepta Therapeutics, Inc. (SRPT) uchun noyob gen terapiyalariga nisbatan monopol narx belgilash imkoniyati bilan belgilanadi va bozorga muqobillarning yo'qligi sababli kompaniyaga yuqori rentabellikni saqlab qolish imkonini beradi.

Sarepta Therapeutics, Inc. (SRPT) raqobatchilari

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|Sof marja Twist Bioscience|TXG (10x Genomics) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX